anti-angiogenic drugs

anti-angiogenic drugs

A group of currently experimental anticancer drugs that act by inhibiting the growth of the small blood vessels on which cancers depend for their growth. The group includes ANGIOSTATIN, ENDOSTATIN, THALIDOMIDE, SQUALAMINE, 2-methoxy-oestradiol (estradiol), vitaxin and marimastat.